These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 15203988)

  • 41. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
    Qiu J; Lil GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W; Song HP
    Hepatogastroenterology; 2007; 54(75):681-7. PubMed ID: 17591041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploiting dendritic cells in the development of cancer vaccines.
    Bracci L; Capone I; Moschella F; Proietti E; Belardelli F
    Expert Rev Vaccines; 2013 Oct; 12(10):1195-210. PubMed ID: 24090117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
    Seremet T; Brasseur F; Coulie PG
    Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimizing dendritic cell-based immunotherapy for cancer.
    Zhong H; Shurin MR; Han B
    Expert Rev Vaccines; 2007 Jun; 6(3):333-45. PubMed ID: 17542749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
    Rolinski J; Hus I
    J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic-cell-based therapeutic vaccination against cancer.
    Nestle FO; Farkas A; Conrad C
    Curr Opin Immunol; 2005 Apr; 17(2):163-9. PubMed ID: 15766676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
    Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dendritic cells transduced with recombinant adenoviruses induce more efficient anti-tumor immunity than dendritic cells pulsed with peptide.
    Oh ST; Kim CH; Park MY; Won EH; Sohn HJ; Cho HI; Kang WK; Hong YK; Kim TG
    Vaccine; 2006 Apr; 24(15):2860-8. PubMed ID: 16443309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients.
    Bercovici N; Haicheur N; Massicard S; Vernel-Pauillac F; Adotevi O; Landais D; Gorin I; Robert C; Prince HM; Grob JJ; Leccia MT; Lesimple T; Wijdenes J; Bartholeyns J; Fridman WH; Salcedo M; Ferries E; Tartour E
    J Immunother; 2008 Jan; 31(1):101-12. PubMed ID: 18157017
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dendritic cells as therapeutic vaccines against cancer.
    Banchereau J; Palucka AK
    Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Vaccinal cell therapy in melanoma].
    Quillien V; Lesimple T; Toujas L
    Bull Cancer; 2003; 90(8-9):722-33. PubMed ID: 14609762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [General principles and first clinical trials of therapeutic vaccines against cancer].
    Baurain JF; Van der Bruggen P; Van den Eynde BJ; Coulie PG; Van Baren N
    Bull Cancer; 2008 Mar; 95(3):327-35. PubMed ID: 18390413
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
    Spisek R
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
    [No Abstract]   [Full Text] [Related]  

  • 54. Dendritic cells and immunotherapy for malignant disease.
    Reid DC
    Br J Haematol; 2001 Mar; 112(4):874-87. PubMed ID: 11298582
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical applications of dendritic cell cancer vaccines.
    Baar J
    Oncologist; 1999; 4(2):140-4. PubMed ID: 10337385
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic cancer vaccines.
    Morris LF; Ribas A
    Surg Oncol Clin N Am; 2007 Oct; 16(4):819-31, ix. PubMed ID: 18022546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dendrite cell-based cancer vaccines--clinical application].
    Svane IM; Berntsen A; Trepiakas R; Pedersen AE
    Ugeskr Laeger; 2006 Apr; 168(14):1415-20. PubMed ID: 16584668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Dendritic cell-based cancer vaccine].
    Burgdorf SK; Claësson MH; Rosenberg J
    Ugeskr Laeger; 2006 Apr; 168(14):1420-3. PubMed ID: 16584669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunotherapy with dendritic cells for cancer.
    Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A
    Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dendritic cell preparation for immunotherapeutic interventions.
    Simon T; Fonteneau JF; Grégoire M
    Immunotherapy; 2009 Mar; 1(2):289-302. PubMed ID: 20635946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.